Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An announcement from Quanterix ( (QTRX) ) is now available.
Quanterix Corporation has announced the acquisition of Emission Inc., a company known for its proprietary bead technology used in multi-plex assays. The acquisition, valued at up to $70 million based on performance milestones, is expected to enhance Quanterix’s technology stack and expand its market reach through vertical integration and OEM business opportunities. This strategic move aims to secure critical components for Quanterix’s platforms and support the company’s growth in the diagnostics industry.
More about Quanterix
Quanterix Corporation is a company involved in the field of ultrasensitive biomarker detection, offering products and services that advance disease research and diagnostics across several medical domains, including neurology, oncology, immunology, cardiology, and infectious disease. The company is known for its Simoa technology, which allows for the detection of proteins at levels lower than conventional methods, and has been a key player in scientific research for nearly two decades.
YTD Price Performance: -58.27%
Average Trading Volume: 402,462
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $437.9M
For a thorough assessment of QTRX stock, go to TipRanks’ Stock Analysis page.
